T3D Therapeutics

News

T3D Therapeutics’ drug explores the link between diabetes and Alzheimer’s disease

There’s a growing consensus that two of society’s most rampant public health issues – Type II Diabetes and Alzheimer’s disease – are intertwined. It’s not all about clearing plaques anymore: Insulin modulation is askew in both diseases, which has led researchers to examine sugar metabolism’s link to cognitive decline. North Carolina startup T3D Therapeutics is actually repurposing a […]